Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer’s disease continuum
Authors
Keywords
-
Journal
Alzheimers Research & Therapy
Volume 15, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-28
DOI
10.1186/s13195-023-01336-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain
- (2023) Martí Colom-Cadena et al. NEURON
- Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer’s disease and frontotemporal dementia
- (2023) Shreyasee Das et al. Alzheimers Research & Therapy
- Synaptic density and cognitive performance in Alzheimer's disease: A PET imaging study with [ 11 C]UCB‐J
- (2022) Adam P. Mecca et al. Alzheimers & Dementia
- Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration
- (2022) Alba Cervantes González et al. Molecular Neurodegeneration
- Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
- (2022) Pia Kivisäkk et al. Alzheimers Research & Therapy
- Microtubule assembly by tau impairs endocytosis and neurotransmission via dynamin sequestration in Alzheimer’s disease synapse model
- (2022) Tetsuya Hori et al. eLife
- P-tau subgroups in AD relate to distinct amyloid production and synaptic integrity profiles
- (2022) Kirsten E. J. Wesenhagen et al. Alzheimers Research & Therapy
- Quantification of SNAP-25 with mass spectrometry and Simoa: a method comparison in Alzheimer’s disease
- (2022) Johanna Nilsson et al. Alzheimers Research & Therapy
- Cerebrospinal fluid biomarker panel of synaptic dysfunction in Alzheimer's disease and other neurodegenerative disorders
- (2022) Johanna Nilsson et al. Alzheimers & Dementia
- CSF Synaptic Biomarkers in the Preclinical Stage of Alzheimer Disease and Their Association With MRI and PET: A Cross-sectional Study
- (2021) Marta Milà-Alomà et al. NEUROLOGY
- VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome
- (2021) Alberto Lleó et al. Alzheimers Research & Therapy
- An atlas of the protein-coding genes in the human, pig, and mouse brain
- (2020) Evelina Sjöstedt et al. SCIENCE
- Amyloid-β Peptides Disrupt Interactions Between VAMP-2 and SNAP-25 in Neuronal Cells as Determined by FRET/FLIM
- (2020) Nidhi Sharda et al. JOURNAL OF ALZHEIMERS DISEASE
- Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0
- (2020) Nathalie Percie du Sert et al. PLOS BIOLOGY
- Full-length and C-terminal neurogranin in Alzheimer’s disease cerebrospinal fluid analyzed by novel ultrasensitive immunoassays
- (2020) Annika Öhrfelt et al. Alzheimers Research & Therapy
- Changes in synaptic proteins precede neurodegeneration markers in preclinical Alzheimer’s disease cerebrospinal fluid
- (2019) Alberto Lleó et al. MOLECULAR & CELLULAR PROTEOMICS
- A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer’s disease
- (2019) Nicholas J. Ashton et al. Science Advances
- Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse
- (2019) Daniel Alcolea et al. Annals of Clinical and Translational Neurology
- NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
- (2018) Clifford R. Jack et al. Alzheimers & Dementia
- Sex, amyloid, and APOE ε4 and risk of cognitive decline in preclinical Alzheimer's disease: Findings from three well-characterized cohorts
- (2018) Rachel F. Buckley et al. Alzheimers & Dementia
- Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
- (2018) Flora H. Duits et al. Alzheimers Research & Therapy
- Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
- (2018) Ming-Kai Chen et al. JAMA Neurology
- Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology
- (2018) Åsa Sandelius et al. Alzheimers & Dementia
- Safety, tolerability and efficacy of the glutaminyl cyclase inhibitor PQ912 in Alzheimer’s disease: results of a randomized, double-blind, placebo-controlled phase 2a study
- (2018) Philip Scheltens et al. Alzheimers Research & Therapy
- Tau association with synaptic vesicles causes presynaptic dysfunction
- (2017) Lujia Zhou et al. Nature Communications
- Meta-analysis of synaptic pathology in Alzheimer's disease reveals selective molecular vesicular machinery vulnerability
- (2016) Martijn C. de Wilde et al. Alzheimers & Dementia
- The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease
- (2016) Annika Öhrfelt et al. Alzheimers Research & Therapy
- C-terminal neurogranin is increased in cerebrospinal fluid but unchanged in plasma in Alzheimer's disease
- (2015) Ann De Vos et al. Alzheimers & Dementia
- Postsynaptic VAMP/Synaptobrevin Facilitates Differential Vesicle Trafficking of GluA1 and GluA2 AMPA Receptor Subunits
- (2015) Suleman Hussain et al. PLoS One
- Amyloid-β Oligomers May Impair SNARE-Mediated Exocytosis by Direct Binding to Syntaxin 1a
- (2015) Yoosoo Yang et al. Cell Reports
- A Practical Guide to Immunoassay Method Validation
- (2015) Ulf Andreasson et al. Frontiers in Neurology
- Composition of isolated synaptic boutons reveals the amounts of vesicle trafficking proteins
- (2014) B. G. Wilhelm et al. SCIENCE
- Measuring cognitive change in subjects with prodromal Alzheimer's disease
- (2013) T. Mura et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease
- (2012) Nicole C. Berchtold et al. NEUROBIOLOGY OF AGING
- Proteasome Inhibition Alleviates SNARE-Dependent Neurodegeneration
- (2012) M. Sharma et al. Science Translational Medicine
- Revised criteria for diagnosis of Alzheimer’s disease: National Institute on Aging-Alzheimer's Association diagnostic guidelines for Alzheimer's disease
- (2011) Zaven S. Khachaturian Alzheimers & Dementia
- Toward defining the preclinical stages of Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- VAMP-2, SNAP-25A/B and syntaxin-1 in glutamatergic and GABAergic synapses of the rat cerebellar cortex
- (2011) Vincenzo Benagiano et al. BMC NEUROSCIENCE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started